Franco Poletti - 30 Mar 2025 Form 4 Insider Report for LivaNova PLC (LIVN)

Role
President, Cardiopulmonary
Signature
/s/ Sarah K. Mohr, Attorney-in-Fact
Issuer symbol
LIVN
Transactions as of
30 Mar 2025
Net transactions value
-$21,208
Form type
4
Filing time
01 Apr 2025, 21:00:26 UTC
Previous filing
17 Dec 2024
Next filing
17 Sep 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIVN Ordinary Shares Options Exercise $0 +1,257 +17% $0.000000 8,475 30 Mar 2025 Direct F1
transaction LIVN Ordinary Shares Tax liability $21,208 -542 -6.4% $39.13 7,933 30 Mar 2025 Direct
holding LIVN Ordinary Shares 219 30 Mar 2025 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIVN Restricted Stock Units Options Exercise $0 -201 -100% $0.000000 0 30 Mar 2025 Ordinary Shares 201 Direct F2, F3
transaction LIVN Restricted Stock Units Options Exercise $0 -172 -50% $0.000000 171 30 Mar 2025 Ordinary Shares 172 Direct F2, F4
transaction LIVN Restricted Stock Units Options Exercise $0 -325 -33% $0.000000 650 30 Mar 2025 Ordinary Shares 325 Direct F5, F6
transaction LIVN Restricted Stock Units Options Exercise $0 -559 -25% $0.000000 1,675 30 Mar 2025 Ordinary Shares 559 Direct F5, F7
transaction LIVN Restricted Stock Units Award $0 +6,388 $0.000000 6,388 30 Mar 2025 Ordinary Shares 6,388 Direct F5, F8
transaction LIVN Performance Stock Units Award $0 +3,194 $0.000000 3,194 30 Mar 2025 Ordinary Shares 3,194 Direct F9, F10
transaction LIVN Performance Stock Units Award $0 +3,194 $0.000000 3,194 30 Mar 2025 Ordinary Shares 3,194 Direct F9, F11
transaction LIVN Performance Stock Units Award $0 +6,388 $0.000000 6,388 30 Mar 2025 Ordinary Shares 6,388 Direct F9, F12
transaction LIVN Stock Appreciation Rights Award $0 +13,986 $0.000000 13,986 30 Mar 2025 Ordinary Shares 13,986 $39.13 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.
F2 Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement.
F3 On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.
F4 On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement.
F5 Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.
F6 On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.
F7 On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.
F8 On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.
F9 Each performance stock unit (PSU) represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement.
F10 On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's free cash flow (FCF) for performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
F11 On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
F12 On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.
F13 On March 30, 2025, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.